With regard to our data, higher PPARγ expression is correlated with shorter survival in pancreatic ductal adenocarcinoma [26] and prostate cancer [27] and with the onset and progression of ovarian cancer [28]. This evidence concerns the gene PPARG and ovarian carcinoma.